According to the report:
• Primary hip replacement procedures were the second most predominantly performed hip and knee implant replacement procedure in 2013, behind knee arthroplasty.
• As of 2013, X-linked PE bearings comprised the vast majority of implants used.
• The high profile failure of some metal-on-metal bearings led the U.S. Food and Drug Administration to examine the efficacy and safety of five new implants used in major joint reconstruction surgeries. The research found no convincing evidence supporting the use of the newer devices.
• Vitamin E is starting to become more prevalent in the orthopedics industry, most commonly used in hip, shoulder and knee implants.
More articles on devices:
K2M stock hits crucial point — 5 things to know
Providence Medical Technology gets 3 spine-related patents
Amedica appoints Anan Natarajan vice president of business development
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
